Trinity Biotech reported $2.38M in Ordinary Share Capital for its fiscal quarter ending in September of 2024.


Ordinary Share Capital Change Date
Abbott USD 25.12B 28M Mar/2025
Bayer EUR 982.42M 1.53B Jun/2025
Bio-Rad Laboratories USD 27.06M 27.06M Jun/2025
EDAP TMS EUR 4.89M 37K Dec/2024
J&J USD 3.12B 0 Mar/2025
Roche Holding CHF 107M 0 Jun/2024
Siemens EUR 787.07M 1.61B Jun/2025
Thermo Fisher Scientific USD 377.49M 66.51M Jun/2025
Tosoh JPY 318.51M 54.85B Jun/2025
Trinity Biotech USD 2.38M 39K Sep/2024
Veracyte USD 78.32M 78.24M Jun/2025